{
    "title": "Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5125125/Merck-KGaA-Pfizers-immunotherapy-fails-gastric-cancer-trial.html",
    "date": "2017-11-28",
    "keywords": [
        "cancer",
        "trial",
        "merck",
        "bavencio",
        "treatment",
        "burger",
        "development",
        "chemotherapy",
        "avelumab",
        "pfizer",
        "statement",
        "year",
        "class",
        "javelin",
        "kgaa",
        "setback",
        "immunotherapy",
        "goal",
        "survival",
        "type",
        "bladder",
        "lung",
        "opportunity",
        "drug",
        "entrant",
        "pdl1",
        "pd1",
        "immune",
        "system",
        "attack",
        "mechanism",
        "tumours",
        "use",
        "detection",
        "tecentriq",
        "astrazenecas",
        "imfinzi",
        "blockbuster",
        "potential",
        "stock",
        "percent",
        "gmt",
        "analyst",
        "umer",
        "raffat",
        "bavencioavelumab",
        "placebo",
        "benchmark",
        "study",
        "risk",
        "fact",
        "work",
        "doesnt",
        "efficacy",
        "vs",
        "opdivokeytruda",
        "etc",
        "note",
        "programme",
        "monotherapy",
        "range",
        "immunooncology",
        "disappointment",
        "reporting",
        "jane",
        "merriman",
        "greg",
        "mahlich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}